AVCNF
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
23.84M
PRFX
Price
$1.42
Change
-$0.05 (-3.40%)
Updated
Aug 29, 04:08 PM (EDT)
Capitalization
2.96M
76 days until earnings call
Interact to see
Advertisement

AVCNF vs PRFX

Header iconAVCNF vs PRFX Comparison
Open Charts AVCNF vs PRFXBanner chart's image
Avicanna
Price$0.20
Change-$0.00 (-0.00%)
Volume$159.01K
Capitalization23.84M
PainReform
Price$1.42
Change-$0.05 (-3.40%)
Volume$3.7K
Capitalization2.96M
AVCNF vs PRFX Comparison Chart in %
Loading...
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCNF vs. PRFX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCNF is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AVCNF: $0.20 vs. PRFX: $1.47)
Brand notoriety: AVCNF and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AVCNF: 239% vs. PRFX: 6%
Market capitalization -- AVCNF: $23.84M vs. PRFX: $2.96M
AVCNF [@Pharmaceuticals: Generic] is valued at $23.84M. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $2.96M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCNF’s FA Score shows that 0 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • AVCNF’s FA Score: 0 green, 5 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, PRFX is a better buy in the long-term than AVCNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCNF’s TA Score shows that 5 TA indicator(s) are bullish while PRFX’s TA Score has 5 bullish TA indicator(s).

  • AVCNF’s TA Score: 5 bullish, 5 bearish.
  • PRFX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both AVCNF and PRFX are a good buy in the short-term.

Price Growth

AVCNF (@Pharmaceuticals: Generic) experienced а +2.56% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -9.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

PRFX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCNF($23.8M) has a higher market cap than PRFX($2.96M). AVCNF YTD gains are higher at: 0.542 vs. PRFX (-56.185). AVCNF has higher annual earnings (EBITDA): -1.47M vs. PRFX (-17.81M). PRFX has less debt than AVCNF: PRFX (59K) vs AVCNF (73.5K). AVCNF has higher revenues than PRFX: AVCNF (25.3M) vs PRFX (0).
AVCNFPRFXAVCNF / PRFX
Capitalization23.8M2.96M804%
EBITDA-1.47M-17.81M8%
Gain YTD0.542-56.185-1%
P/E RatioN/AN/A-
Revenue25.3M0-
Total Cash457KN/A-
Total Debt73.5K59K125%
FUNDAMENTALS RATINGS
AVCNF: Fundamental Ratings
AVCNF
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVCNFPRFX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 5 days ago
87%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVCNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPPM0.06N/A
N/A
TMPOS Inc
SDCH0.10N/A
N/A
SideChannel Inc.
VMTHF0.25N/A
N/A
VENUS MEDTECH HANGZHOU INC.
IRRHF2962.74N/A
N/A
Interroll Holdings SA
ALBHF0.66-0.07
-9.84%
Alibaba Health Information Technology Ltd

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
+3.32%
PRFX - AVCNF
20%
Poorly correlated
-8.70%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
N/A
APNHY - AVCNF
7%
Poorly correlated
+1.42%
BKUH - AVCNF
5%
Poorly correlated
N/A
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and EVOK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and EVOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
-8.70%
EVOK - PRFX
24%
Poorly correlated
-3.64%
AMRX - PRFX
24%
Poorly correlated
+2.03%
LFCR - PRFX
21%
Poorly correlated
+1.20%
AYURF - PRFX
21%
Poorly correlated
N/A
KMDA - PRFX
21%
Poorly correlated
-1.54%
More